Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine + treosulfan conditioning before peripheral blood stem cell transplantation in advanced hematological malignancies
2008-006972-31Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Nov 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clofarabine and treosulfan in hematopoietic malignancies, sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Non-relapse mortality at day +100. Started Nov 2008; status: completed.
02
Drugs
clofarabinetreosulfan
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on 2008-006972-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006972-31.